Larry Husten, CardioBrief

The 25% reduction in relative risk seen in patients treated to 120 vs 140 mm Hg corresponds to an absolute risk reduction of 1.6%.

Critics continue to call for independent analysis by outside investigators not involved with the original trial.

Even experts involved in clinical trials of the at-home saliva test say it has no place in routine clinical practice.